Skip to content

Clinical trials

Phase 2/3 trials in Estonia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Estonia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20091
20101
20131
20152
20163
20171
20192
20201
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
ASLAN Pharmaceuticals1
AbbVie1
Astellas Pharma Europe B.V.1
AstraZeneca1
EyeBiotech Ltd.1
IVERIC bio, Inc.1
Institut National de la Santé Et de la Recherche Médicale, France1
Kartos Therapeutics, Inc.1
MacroGenics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid2
Multiple Sclerosis, Chronic Progressive2
Choroidal Neovascularization1
Colitis, Ulcerative1
Demyelinating Diseases1
Dental Caries1
Diabetes Mellitus, Type 11
Ductus Arteriosus, Patent1
Endometrial Neoplasms1
Generalized Anxiety Disorder1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.